Wockhardt, Serum Life Sciences partner to manufacture vaccines in UK

Wockhardt Limited said that it has signed a collaboration agreement through its subsidiary with Serum Life Sciences Ltd, UK, which in turn is a subsidiary of the Serum Institute of India, for delivering a global vaccine program from its new facility in the UK.

The collaboration will lead to a profit sharing arrangement between the two parties that will be delivering up to an additional 150 million vaccine doses of various vaccines each year.